Christina Mastori Kourmpani

Dr. Christina Mastori Kourmpani

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAndreas Sarantopoulos
Andreas Sarantopoulos
CKChristina Mastori Kourmpani
Christina Mastori Kourmpani
AYAtshaya Lily Yokarasa
Atshaya Lily Yokarasa
CMChiedza Makamanzi
Chiedza Makamanzi
PAPolyna Antoniou
Polyna Antoniou
Constantinos TsioutisConstantinos Tsioutis
Constantinos Tsioutis
The integration of artificial intelligence (AI) in clinical medicine marks a revolutionary shift, enhancing diagnostic accuracy, therapeutic efficacy, and overall healthcare delivery. This review explores the current uses, benefits, limitations, and future applications of AI in infectious diseases, highlighting its specific applications in diagnostics, clinical decision making, and personalized medicine. The transformative potential of AI in infectious diseases is emphasized, addressing gaps in rapid and accurate disease diagnosis, surveillance, outbreak detection and management, and treatment optimization. Despite these advancements, significant limitations and challenges exist, including data privacy concerns, potential biases, and ethical dilemmas. The article underscores the need for stringent regulatory frameworks and inclusive databases to ensure equitable, ethical, and effective AI utilization in the field of clinical and laboratory infectious diseases.

20 March 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
AAAris P. Agouridis
Aris P. Agouridis
CKChristina Mastori Kourmpani
Christina Mastori Kourmpani
PAPolyna Antoniou
Polyna Antoniou
PKPaschalis Konstantinou
Paschalis Konstantinou
EREvangelos Rizos
Evangelos Rizos
Constantinos TsioutisConstantinos Tsioutis
Constantinos Tsioutis
Background: Beau’s lines are transverse grooves in the nail plate that result from transient interruption of the growth of the proximal nail matrix after severe disease. The aim of this study is to systematically report all evidence on the association of Beau’s lines with COVID-19 infection or vaccination against COVID-19. Methods: PubMed and Scopus databases were searched up to January 2024 for articles reporting Beau’s lines associated with COVID-19 infection or vaccination for COVID-19. PROSPERO ID: CRD42024496830. Results: PubMed search identified 299 records while Scopus search identified 18 records. After screening the bibliography, nine studies including 35 cases were included in our systematic review. The studies were reported from different areas around the world. Included studies documented Beau’s lines following COVID-19 vaccination (two studies) or after COVID-19 infection (seven studies). High variability was recorded in onset and resolution times among included cases, averaging 3 months and 6 months after COVID-19 infection, respectively. In the two studies reporting Beau’s lines after vaccination, onset was at 7 days and 6 weeks and resolution occurred after 8 and 17 weeks, respectively. Conclusions: To the best of our knowledge, this is the first systematic review reporting the association of Beau’s lines with COVID-19 infection and vaccination. Severe immune response can result in the formation of these nail disorders. Of importance, Beau’s lines represent a potential indicator of prior severe COVID-19 infection or vaccination for COVID-19, as well as a sign of long COVID-19 syndrome.

5 August 2025 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
CKChristina Mastori Kourmpani
Christina Mastori Kourmpani
AMAnastasios Makris
Anastasios Makris
Evangelos LiberopoulosEvangelos Liberopoulos
Evangelos Liberopoulos
PSPetros P. Sfikakis
Petros P. Sfikakis
AAAris P. Agouridis
Aris P. Agouridis